US BANCORP \DE\ - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$787,445
+1.4%
6,496
-4.2%
0.00%0.0%
Q2 2023$776,216
-36.6%
6,778
-23.6%
0.00%
-50.0%
Q1 2023$1,223,517
+13.0%
8,877
+6.3%
0.00%0.0%
Q4 2022$1,082,382
-20.6%
8,353
-32.4%
0.00%
-33.3%
Q3 2022$1,364,000
+46.8%
12,355
-0.3%
0.00%
+50.0%
Q2 2022$929,000
-0.9%
12,395
+3.3%
0.00%0.0%
Q1 2022$937,000
-15.4%
12,003
-2.5%
0.00%0.0%
Q4 2021$1,107,000
+10.9%
12,309
+14.1%
0.00%0.0%
Q3 2021$998,000
+25.5%
10,790
+5.5%
0.00%
+100.0%
Q2 2021$795,000
+19.9%
10,224
+15.2%
0.00%0.0%
Q1 2021$663,000
-25.5%
8,874
+70.0%
0.00%
-50.0%
Q4 2020$890,000
+159.5%
5,220
+114.0%
0.00%
+100.0%
Q3 2020$343,000
-8.5%
2,439
+4.3%
0.00%0.0%
Q2 2020$375,000
+63.0%
2,339
-0.5%
0.00%0.0%
Q1 2020$230,000
-22.0%
2,351
+3.2%
0.00%0.0%
Q4 2019$295,000
+58.6%
2,279
-7.4%
0.00%0.0%
Q3 2019$186,000
+2.8%
2,462
+106.4%
0.00%0.0%
Q2 2019$181,000
+48.4%
1,193
+16.1%
0.00%
Q1 2019$122,000
+18.4%
1,028
+9.0%
0.00%
Q4 2018$103,000
-31.8%
943
+1.4%
0.00%
Q3 2018$151,000
-21.8%
930
-36.3%
0.00%
-100.0%
Q2 2018$193,000
+12.2%
1,460
-36.9%
0.00%0.0%
Q1 2018$172,000
-26.8%
2,315
-45.2%
0.00%0.0%
Q4 2017$235,000
+65.5%
4,224
+35.0%
0.00%
Q3 2017$142,000
+61.4%
3,129
+19.2%
0.00%
Q2 2017$88,000
+29.4%
2,624
+14.2%
0.00%
Q1 2017$68,000
+88.9%
2,298
+72.9%
0.00%
Q4 2016$36,000
+414.3%
1,329
+1007.5%
0.00%
Q3 2016$7,000
+250.0%
1200.0%0.00%
Q2 2016$2,0000.0%1200.0%0.00%
Q1 2016$2,000
-60.0%
1200.0%0.00%
Q4 2015$5,000
+25.0%
1200.0%0.00%
Q3 2015$4,0000.0%1200.0%0.00%
Q2 2015$4,000
+100.0%
1200.0%0.00%
Q1 2015$2,0000.0%1200.0%0.00%
Q4 2014$2,000
-33.3%
1200.0%0.00%
Q3 2014$3,000
-25.0%
1200.0%0.00%
Q2 2014$4,000
-42.9%
120
-55.9%
0.00%
Q1 2014$7,000
+250.0%
272
+126.7%
0.00%
Q4 2013$2,000
-98.5%
120
-95.6%
0.00%
-100.0%
Q3 2013$130,0002,7550.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,315,000$170,397,70013.20%
EcoR1 Capital, LLC 2,999,453$388,669,12011.83%
Evolutionary Tree Capital Management, LLC 63,756$8,261,5027.93%
Tri Locum Partners LP 119,695$15,510,0006.27%
Avoro Capital Advisors LLC 3,175,000$411,416,5006.15%
Camber Capital Management LP 1,250,000$161,9755.56%
Finepoint Capital LP 131,457$17,0345.51%
ACUTA CAPITAL PARTNERS, LLC 67,500$8,746,6505.38%
Logos Global Management LP 220,000$28,507,6003.34%
AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP 33,454$3,401,6573.20%
View complete list of SAREPTA THERAPEUTICS INC shareholders